| 291 |
New nitazoxanide derivatives: design, synthesis, biological evaluation, and molecular docking studies as antibacterial and antimycobacterial agents |
Department of Pharmaceutical Organic Chemistry |
2023 |
| 292 |
NiFe‑based Prussian blue analogue nanopolygons hybridized with functionalized glyoxal polymer as a voltammetric platform for the determination of amisulpride in biological samples |
Department of Pharmaceutical Analytical Chemistry |
2023 |
| 293 |
Non-coding RNA-directed therapeutics in lung cancer: Delivery technologies and clinical applications |
Department of Industrial Pharmacy |
2023 |
| 294 |
Novel Drugs Obtained via Biotransformation—In Memory of the Late Scientists Frieder Schauer and Peter Grunwald |
|
2023 |
| 295 |
Novel fluoroquinolone hybrids as dual DNA gyrase and urease inhibitors with potential antibacterial activity: Design, synthesis, and biological evaluation |
Department of Pharmaceutical Organic Chemistry |
2023 |
| 296 |
Novel piperine carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway |
Department of Pharmaceutical Organic Chemistry |
2023 |
| 297 |
Oral proniosomal amitriptyline and liraglutide for management of diabetic neuropathy: Exceptional control over hyperglycemia and neuropathic pain |
Department of Pharmaceutics |
2023 |
| 298 |
Phage therapy, a salvage treatment for multidrug-resistant bacteria causing infective endocarditis |
|
2023 |
| 299 |
Phenotypic and genotypic characterization of carbapenemases in carbapenem-resistant gram-negative bacilli isolated from adult cancer patients |
Department of Microbiology and Immunology |
2023 |
| 300 |
Phytochemical analysis and anti-infective potential of fungal endophytes isolated from Nigella sativa seeds |
Department of Pharmaceutical Organic Chemistry |
2023 |
Do you have any questions? (088) 2080369 - 2345622 Pharmacy_QAAU@pharm.aun.edu.eg
